Show
Sort by
-
- Journal Article
- A1
- open access
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use
-
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
Improved outcome prediction of children with neuroblastoma using an integrated miRNA and DNA methylation signature
-
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
-
miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples
-
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
-
Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
-
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification
-
Predicting outcomes for children with neuroblastoma
-
Detection of DNA copy number alterations in cancer by array comparative genomic hybridization
-
ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value